Showing results (121-130 of 253) with videos related to

Sort By:
Pageof 26
Plos Pathogens|September 13, 2011
HTLV-1 propels thymic human T cell development in "human immune system" Rag2⁻/⁻ gamma c⁻/⁻ miceJulien Villaudy, Mélanie Wencker, Nicolas Gadot, et al.
Iscience|August 24, 2019
Fate Distribution and Regulatory Role of Human Mesenchymal Stromal Cells in Engineered Hematopoietic Bone OrgansPaul E Bourgine, Kristin Fritsch, Sebastien Pigeot, et al.
The Journal of Clinical Investigation|September 11, 2009
Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human componentsMartha R Neagu, Patrick Ziegler, Thomas Pertel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2019
Long-Term Follow-Up of Antibody Titers Against Measles, Mumps, and Rubella in Recipients of Allogenic Hematopoietic Cell TransplantationJan Bögeholz, Norman F Russkamp, Christian M Wilk, et al.
Transfusion|August 13, 2015
Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costsTarun Mehra, Burkhardt Seifert, Silvina Bravo-Reiter, et al.
Journal for Immunotherapy of Cancer|January 23, 2023
Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case reportChristian Koch, Juliane Fleischer, Todor Popov, et al.
Anaesthesia|August 27, 2019
Impact of a Patient Blood Management monitoring and feedback programme on allogeneic blood transfusions and related costsA Kaserer, J Rössler, J Braun, et al.
Blood|August 31, 2016
MPL expression on AML blasts predicts peripheral blood neutropenia and thrombocytopeniaPhilipp J Rauch, Jana M Ellegast, Corinne C Widmer, et al.
Bioconjugate Chemistry|June 10, 2020
Impact of Ligand Size and Conjugation Chemistry on the Performance of Universal Chimeric Antigen Receptor T-Cells for Tumor KillingChristian Pellegrino, Nicholas Favalli, Michael Sandholzer, et al.
Neuro-Oncology|June 19, 2023
Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastomaLena Hänsch, Matthias Peipp, Maximilian Mastall, et al.
Pageof 26